Si-Bone Inc (SIBN) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Si-Bone Inc stock $17.89, price $23.41, that is 23.6% below the price, quality 48 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Si-Bone Inc
SIBN · USExpensive (fair value 24% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range $11.23 – $28.90 · fair‑value band $13.42 – $22.37 · the $23.41 price screens above the $17.89 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Si-Bone is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally.
Show moreShow less
It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium.
The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Stock analysis
Si-Bone Inc (SIBN) currently trades at $23.41, while our estimate is $17.89, 24% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $13.42 (bear) to $22.37 (bull), the price of $23.41 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Si-Bone Inc reported revenue of $201M in FY2025 versus $90.2M in FY2021, a compound +22.2%/yr. Reported net income was −$18.9M in FY2025.
Key figures
Market cap $1.0B Small · P/S ratio 4.96 · EPS (TTM) $−0.3100 · Net margin −6.2% · Return on equity −7.7% · Return on assets (EBIT) −22.0% (5-year average) · Operating margin −7.8% · Revenue (TTM) $221M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).
What moves the price
The share trades about 9% below its 52-week high and 102% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −24%, SIBN screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, 5 officers or directors sold shares worth $9.3M and none bought.
- SaleMichael A. PisetskySVP, Ops & Adm/Chief Legal Ofr12× since Nov 17, 2025: 130,302 shares, avg. $20.56$2.7MNov 4, 2026
- SaleLaura FrancisChief Executive Officer, Director8× since Nov 17, 2025: 334,925 shares, avg. $19.39$6.5MNov 4, 2026
- SaleAnshul MaheshwariChief Op & Financial Officer14× since Nov 17, 2025: 106,670 shares, avg. $18.54$2.0MNov 4, 2026
- SaleJeffrey W DunnDirector9× since Dec 8, 2025: 124,249 shares, avg. $19.41$2.4MNov 2, 2026
- SaleTimothy E Davis JRDirector7,280 shares at $14.31$104,187May 29, 2026
- SaleMika NishimuraDirector4,100 shares at $13.83$56,703Mar 12, 2026
- SaleAnthony J RecuperoOther3× since Nov 17, 2025: 28,559 shares, avg. $16.22$463,239Feb 17, 2026
Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
SIBN screens overvalued: fair value 24% below the price. Compare with Abbott Laboratories, →
Compare Si-Bone Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs SIBN |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs SIBN |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs SIBN |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥184.30 | ¥197.34 | +7% | vs SIBN |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs SIBN |
| Siemens Healthineers AG SHL | €44.00 | €34.51 | −22% | vs SIBN |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs SIBN |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs SIBN |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs SIBN |
| Koninklijke Philips N.V PHIA | €27.54 | €15.23 | −45% | vs SIBN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Si-Bone Inc (SIBN) overvalued or undervalued?
What is the fair value of SIBN?
What is the quality score of SIBN?
What is the price target for Si-Bone Inc (SIBN)?
What is the Si-Bone Inc stock forecast for 2026?
What is the revenue of Si-Bone Inc (SIBN)?
What is the intrinsic value of Si-Bone Inc (SIBN)?
Is Si-Bone Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SIBN?
How much is Si-Bone Inc worth?
What do the bullish and bearish scenarios say about SIBN?
How solid is the balance sheet of Si-Bone Inc (SIBN)?
How far is SIBN from its 52-week high?
Which stocks are comparable to Si-Bone Inc?
Is Si-Bone Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Si-Bone Inc (SIBN)?
What should I pay attention to with Si-Bone Inc right now?
Key figures of Si-Bone Inc
How large is the market capitalisation of Si-Bone Inc (SIBN)?
What is the P/S ratio of Si-Bone Inc (SIBN)?
What are the earnings per share of Si-Bone Inc (SIBN)?
What is the net margin of Si-Bone Inc (SIBN)?
What is the return on equity of Si-Bone Inc (SIBN)?
What is the EBIT return on assets of Si-Bone Inc (SIBN)?
What is the operating margin of Si-Bone Inc (SIBN)?
How fast is revenue growing at Si-Bone Inc (SIBN)?
How much free cash flow does Si-Bone Inc (SIBN) generate?
How much net cash does Si-Bone Inc (SIBN) hold?
Watch Si-Bone Inc in the live analysis
One click puts Si-Bone Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.